Opinion: The fight against TB, paused by COVID-19, must resume | Devex devex.com/news/opinion-t…

Appreciations CTO_Mumbai MSF India on analyzing this HUGE pediatric DR-TB cohort for outcomes. So sad to see adolescent challenges, ~1/5 died and ~1/5 lost. We desperately need simpler, safer, shorter regimens, & special support for adolescents!

New paper shows private equity owned nursing homes create worse patient outcomes at higher taxpayer cost. There are some services in which pure profit maximization is incongruent with society's goals. Much of healthcare, criminal justice, and education fall into this category.

Calling world leaders to stand in solidarity with this call to jointly address #COVID19 &TB. "If the same measures (as #COVID19) are taken against TB, we'll make India #TBFree by 2025 as TB too spreads from the droplets of an infected person." - PMO India hindustantimes.com/india-news/hea…

Accountability is tough, Danaher - Cepheid. 24 million COVID19 GX cartridges made. 4.4 million estimated need in Africa. 1.5 million pledged at beginning of pandemic. 0.5 million delivered. How many did you send to DoD or NYC, I wonder? reuters.com/investigates/s…

📣 HOT OFF THE PRESS: The US is averaging 3M covid shots/day - great! So, we are on our way to herd immunity, right?? Not so fast! Our projections 👇 show that starting end of APRIL, #COVIDVaccine uptake will slow down considerably. 🧵 1/8

International investment is incredibly important here. I'd so much prefer an additional 1000 genomes from South America or Africa to an additional 10,000 from the US or Europe. 14/14

Here's our response to statement made by the European Commission in a WTO meeting regarding #TRIPSwaiver. Scale up of production of COVID medical tools can only happen if low and middle income countries are empowered through suspension of IP monopolies and technology transfer

As countries will be meeting again to discuss #TRIPSwaiver @WTO on 30th April, can America be the first among all opposing countries to support this game-changing waiver and move ahead with the actual negotiations. So far opposing countries continue to stall the process .

Over 100 low and middle income countries are supporting this waiver and calling for suspension of intellectual property on all #COVID medical tools so that they can have a legal tool to enable local production and scale up.

Infections, deaths and breakdowns that began in big cities a few weeks ago are rapidly advancing into rural areas, unleashing deep fear in places with little medical safety net. Chapal Mehra Lancelot Pinto Ministry of Health Anant Bhan TB Harega Desh Jeetega Adithya M Reddy nytimes.com/2021/05/11/wor…

wired.com/story/the-teen… It was obvious from the beginning, from the Skagit Valley choir onwards. like TB, SARS-COV2 was airborne. Maybe it was because the implications were so awful, but public health went into denial. That denial cost countless lives.

The Situation in rural areas in UP and Bihar and perhaps other states is very bad. NGOs can do a lot. Govt must give up its regressive policy and freeze the FCRA rules so they can work. Why is there this policy paralysis ?

Today, Surgo Ventures released a survey of 18K US adults revealing top barriers stopping people from getting a #CovidVaccine, state by state. AND the New York Times Opinion turned my guest essay on the topic into an awesome #dataviz. See 🧵👇 for key learnings! 1/9 nytimes.com/interactive/20…

Now that we are seeing vax'd ppl turn up PCR pos, only now will public health leaders FINALLY understand why #rapidtests have always been the appropriate **public health** test. When the question is "Am I infectious", PCR is overly sensitive to reliably answer this.

I thought this was VERY smart. nytimes.com/interactive/20…

Indian Vx manufacturers have played an extremely important role in producing affordable childhood vaccines for LMICs. But the COVID crisis in India is a somber reminder that we need a more diversified Vx supply base. My opinion piece in The New York Times👇 🧵(1/2) nytimes.com/2021/05/20/opi…

It's hard to believe that, at this juncture, anyone can question the safety of mRNA vaccines. Now, after the large Phase 3 placebo-controlled trials of >70,000 participants, 270 million doses have been given without unanticipated, serious side effects. That's very, very unusual.

Girin was the best kind of human, and the best kind of friend. Always learning, questioning, and caring. He leaves a legacy of work, and a legion of people he inspired to serve the way he did - with thoughtfulness, humility, and kindness. We will miss you.

Battling an Ancient Scourge: In “Phantom Plague,” Vidya lays out the long, maddening history of #tuberculosis, from the days it was called consumption to the urgent danger it presents today. Book review by Apoorva Mandavilli nytimes.com/2022/02/05/boo… via New York Times Books Madhu Pai, MD, PhD